Pharmaceutical Technology | Drug Development News & Views …
Pharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.
News - Pharmaceutical Technology
Shionogi awarded $375m from HHS for preventative Covid-19 injectable. Shionogi has been awarded $375m by the US Department of Health and Human Services (HHS) to develop a long-acting therapeutic…
Pharma developments in 2022: what you need to know
Jan 5, 2022 · Pharma: the big picture. While artificial intelligence and robotics continue to gain popularity in the pharma lexicon, Darcy Jimenez took a closer look at more specific ways in which technology can influence drug development research.In a separate article, Manasi Vaidya discovers that, fueled by the successful use of mRNA vaccines in Covid-19, RNA therapeutics are expected to make larger ...
Magazine: The biggest challenges clinical trials will face in 2025
2 days ago · The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new guidance, and broader political shifts. This month’s cover feature examines the biggest factors to keep an eye on as the year unfolds. Also in this issue, we explore the World ...
Latest News - Pharmaceutical Technology
3 days ago · AbbVie and Neomorph link on oncology/immunology glue degraders. AbbVie and Neomorph are forming a partnership and option-to-license agreement to develop molecular glue degraders, aiming to introduce a new…
Ascentage Pharma raises $126m in first biotech IPO of 2025
1 day ago · Ascentage sold 7,325,000 American Depositary shares at $17.25 each. Credit: Andrey Zhuravlev via Getty Images. China-based biotech Ascentage Pharma has raised $126m in a US initial public offering (IPO), marking the first biotech IPO of 2025. The company sold 7,325,000 American Depositary shares at ...
How technology could transform drug research in 2022
Dec 14, 2021 · When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons.The ambitious and lesser-explored methods currently being applied in drug discovery and development, however, could prove to be just as exciting.. A GlobalData survey this year revealed that over 70% of pharma industry respondents anticipate drug ...
Cell and gene therapy approvals drive paradigm change in …
Oct 14, 2024 · From early phase to commercialisation, cell and gene therapies introduce a range of unique challenges – from the complexities of running a patient-centric rare disease trial and the importance of extended follow-up periods for monitoring patient safety and efficacy to the significant cost of treatments and the critical need to demonstrate strong value …
Stealth faces another hurdle as FDA delays decision on Barth …
1 day ago · Despite the delay, Stealth emphasised that the FDA has not raised any safety concerns or requested additional pre-market studies. In the announcement accompanying the extension, Stealth’s CEO Reenie McCarthy said: “We continue to work closely with the agency as it completes its review of the elamipretide NDA and are actively preparing to support broad access to this therapy for individuals ...
Pharmaceutical Technology’s most-read stories of 2023
Dec 19, 2023 · As the year comes to a close, we at Pharmaceutical Technology take stock at some of the biggest headlines of the year. One of the most popular stories on the site was a forward-looking feature that outlined the biggest expected catalysts involving CRISPR gene therapies and posited 2023 as the milestone year for this approach. The interest in this cutting edge technology was unsurprising given ...
- Some results have been removed